Gen-Probe Reports Financial Results for Second Qu...( (3) 2009 and percentage changes incl...),Health

(3) 2009 and percentage changes include transplant diagnostics and genetic testing product sales associated with the Tepnel acquisition.

(4) 2008 figures exclude revenues associated with the Tepnel acquisition, since Tepnel was not part of Gen-Probe in the prior year period.

                              Gen-Probe Incorporated
                         Consolidated Balance Sheets - GAAP
                    (In thousands, except share and per share data)

                                                        June 30,  December 31,
                                                           2009         2008
                                                           ----         ----
                                                       (unaudited)
    Assets
    Current assets:
       Cash and cash equivalents                       $233,506      $60,122
       Marketable securities                            230,698      371,276
       Trade accounts receivable, net of allowance
        for doubtful accounts of $691 and $700 at
        June 30, 2009 and December 31, 2008,
        respectively                                     39,946       33,397
       Accounts receivable - other                        2,852        2,900
       Inventories                                       56,455       54,406
       Deferred income tax                                9,136        7,269
       Prepaid income tax                                 6,863        2,306
       Prepaid expenses                                  13,388       15,094
       Other current assets                               4,322        6,135
                                                          -----        -----
    Total current assets                                597,166      552,905

    Marketable securities, net of current
     portion                                            105,037       73,780
    Property, plant and e
'/>"/>
SOURCE  Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Reports Financial Results for First Quarter 2009
3. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
4. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
5. Tepnel Shareholders Approve Acquisition by Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
7. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
8. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
9. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
10. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference